InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: None

Sunday, 09/16/2018 1:46:03 PM

Sunday, September 16, 2018 1:46:03 PM

Post# of 460673
AVXL 2-73 may be eligible for accelerated approval for treatment of PDD, an unmet need.

Accelerated approval in the EU

https://www.clinicaltherapeutics.com/article/S0149-2918(16)30455-6/fulltext

Accelerated Approval Paths: What they do Mean and What they Should Not Mean?

G. Calvo
Hospital Clinic of Barcelona and University of Barcelona School of Medicine, Barcelona, Spain
PlumX Metrics
https://doi.org/10.1016/j.clinthera.2016.07.012

Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health
https://www.nature.com/articles/s41531-018-0055-3
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News